Debate sobre objetivos de descenso de la presión arterial luego de SPRINT

pp. 372-280

Autores/as

  • Ernesto L. Schiffrin Physician-in-Chief, Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital; Tier 1 Canada Research Chair in Hypertension, Lady Davis Institute for Medical Research; Vice-Chair, Deparment of Medicine, McGill University, Montreal, Quebec, Canada
  • Marcos Marin Staff del Servicio de Hipertensión Arterial del Hospital Italiano de San Justo

DOI:

https://doi.org/10.7775/rac.es.v85.i4.1176

Publicado

01-09-2025

Número

Sección

CONTROVERSIAS